ClinConnect ClinConnect Logo
Search / Trial NCT05785962

Electromyographic Control of the Response in the Application of Vojta Therapy in People With Brain Injury.

Launched by UNIVERSITY OF SALAMANCA · Mar 23, 2023

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a therapy called Vojta Therapy, which focuses on improving the muscles in the abdomen for people who have suffered brain injuries, such as those from a stroke. The researchers want to see how this therapy affects the stabilizing muscles of the trunk before, during, and after the treatment. They will work with two groups of participants: one group will have brain injuries, and the other group will consist of healthy individuals for comparison.

To be eligible for the study, participants with brain injuries need to be between 18 and 80 years old and able to walk, even with some assistance. Healthy participants must also be between 18 and 80 years old and should not have any conditions that could affect their abdominal muscles. During the trial, participants can expect to undergo a standardized intervention protocol, which means they will follow the same steps throughout the study to ensure consistency in the results. This trial is not yet recruiting participants, but it aims to provide important insights into how Vojta Therapy can help strengthen abdominal muscles in individuals with brain injuries.

Gender

ALL

Eligibility criteria

  • Brain injury group
  • Inclusion Criteria :
  • Over 18 and under 80 years of age
  • Persons with a medical diagnosis of brain damage secondary to stroke
  • Have preserved the ability to walk, even with some type of orthopedic some type of orthopedic aid,
  • Exclusion Criteria:
  • Over 80 years
  • Healthy people
  • Group without brain damage
  • Inclusion Criteria :
  • Over 18 and under 80 years of age
  • Healthy people
  • Full cognitive capacity.
  • Exclusion Criteria:
  • Subjects with neuro-muscular pathologies that affect the abdominal muscles, previous surgeries in the area or any chronic neurological or organic disorder that may alter the results.
  • Fever

About University Of Salamanca

The University of Salamanca, one of the oldest and most prestigious universities in Spain, is a leading institution in academic research and clinical trials. With a strong commitment to advancing healthcare and medical science, the university engages in innovative research initiatives that address critical health challenges. Its clinical trial programs are characterized by rigorous scientific methodology, interdisciplinary collaboration, and a focus on ethical standards, ensuring high-quality outcomes that contribute to the advancement of medical knowledge and patient care. The University of Salamanca fosters partnerships with healthcare professionals and industry leaders, positioning itself at the forefront of clinical research and education.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials